4/A
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001855763-22-000020
Chief Financial Officer bought 121 shares at $2.09 ($253)
From the SEC's structured data for this filing
Trades in this filing
Downey Gregory · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-10-14 | Purchase : show line 1 in the form | +121 | $2.09 | $253 | 1,954 | D |
| Open-market purchases · 121 sh · avg $2.09 · $253 | ||||||
Loading xslF345X03/primary_doc.xml…